Literature DB >> 57490

Letter: Levamisole in angio-immunoblastic lymphadenopathy.

J Bensa, J Faure, H Martin, J Sotto, R Schaerer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57490     DOI: 10.1016/s0140-6736(76)92262-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Immunoblastic lymphadenopathy: case report and literature review.

Authors:  A A Cooperberg; M B de Champlain; J Siminovitch; A Rosenberg; J P Schwartz
Journal:  Can Med Assoc J       Date:  1977-07-09       Impact factor: 8.262

2.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

3.  Arthritis and angioimmunoblastic lymphadenopathy.

Authors:  P G Davies; J N Fordham
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

4.  Polyarthritis and angioimmunoblastic lymphadenopathy.

Authors:  N J McHugh; G J Campbell; J J Landreth; M R Laurent
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

5.  Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy).

Authors:  H Knecht; E W Schwarze; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

7.  Angioimmunoblastic lymphadenopathy associated with polyarthritis.

Authors:  R S Rothwell; M J Mant; P Davis
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

8.  Immunoblastic lymphadenopathy: evolution into immunoblastic sarcoma.

Authors:  S Banik; R L Ward; P S Hasleton
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.